Background
There are limited data assessing the predictive value of fraction of exhaled nitric oxide (FENO) for persistence of wheezing, exacerbations, or lung function change over time in infants/toddlers with recurrent wheezing.
Objectives
In an ongoing longitudinal cohort of infants and toddlers with recurrent wheezing compare predictive values of single-breath FENO (SB-FENO), tidal-breathing mixed-expired FENO (tidal-FENO), bronchodilator responsiveness (BDR), and the Castro-Rodriquez asthma predictive index (API) for persistence of wheezing, exacerbations, and lung function change through age 3 yrs.
Methods
Enrollment forced expiratory flows and volumes (iPFTs) were measured in 44 infants/toddlers using the raised-volume rapid thoracoabdominal compression method. SB-FENO was measured at 50 mL/sec, and tidal-FENO was measured during awake tidal breathing. Clinical outcomes were assessed at age 3 yrs. in 42 infants. Follow-up iPFTs were completed between ages 2.5-3 yrs. in 32 subjects.
Results
An enrollment SB-FENO concentration ≥30 ppb predicted persistence of wheezing at age 3 years with a sensitivity of 77%, a specificity of 94%, and an area under the curve (AUC) of 0.86 (95% CI: 0.74 – 0.98). The sensitivity, specificity, positive predictive, and negative predictive values of SB-FENO for persistence of wheezing and exacerbations were superior to tidal-FENO, BDR, and the API. SB-FENO ≥30 ppb and tidal FENO ≥7 ppb measured at enrollment was associated with a decline in both FEV0.5 and FEF25-75 between enrollment and age 3 years.
Conclusions
In wheezy infants/toddlers SB-FENO was superior to tidal-FENO, BDR, and the API in predicting future exacerbations and persistence of wheezing at age 3 years. Both SB-FENO and tidal FENO were associated with lung function decline over time.